Manufacturing

Articles

AzarGen’s biosimilar, made in iBio’s plant-based system, will be compared to the original molecule in pre-clinical studies.

iBio Supports AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

The partnership will provide cost effective biologics for the world market.

Celltrion and Lonza Sign Contract to Manufacture Remsima Drug Substance

A global agreement with Polpharma Biologics gives Sandoz commercialization rights to a proposed biosimilar natalizumab for relapsing-remitting multiple sclerosis.

Sandoz in Deal to Commercialize Biosimilar Natalizumab

The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.

Catalent Invests $200 Million in Wisconsin and Indiana Sites

Experts believe that the contract development and manufacturing organization market will reach $17.38 billion by 2022, with disruptive business models using Industrial Internet of Things (IIot) and single-use technologies proving more profitable and efficient in the long term.

Single-use and IIoT Solutions Expected to Reduce Costs and Enhance Production Efficiency

Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.

Manufacturing License Granted to Alvotech for Biopharma Facility

David Deere is the chief commercialization officer for PaizaBio, a US-based contract manufacturing organization and consulting group with in-country aseptic fill-and-finish operations in Hangzhou, China. Deere is a veteran global pharmaceutical executive whose career path includes Valeant Pharmaceuticals International, F. Hoffman-La Roche and Genentech.

While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation. 

Biosimilars and Healthcare Policy: What China Can Learn from the EU and US

The collaboration will focus on developing manufacturing solutions for biosimilars.

Pall and Aetos Biologics Partner on Biosimilar Manufacturing

Bio-Rad introduces CHT Ceramic Hydroxyapatite XT media and Nuvia HP-Q resin resin for process protein purification.

Chromatography Resin Designed to Boost Process-Scale Productivity

New products were developed as next-generation process intensification technologies, MilliporeSigma reports.

Manufacturing, Biosimilars and Biobetters